Diagnostic options · UAE

BCR-ABL tests in Dubai & UAE

Compare available BCR-ABL tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

600.00–1,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

BCR-ABL test prices

Showing 1–6 of 6 matching tests.

BCR-ABL diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-387 BCR-ABL Gene Rearrangement PCR Quantitative Test This test quantifies the BCR-ABL1 fusion gene transcript level in a blood or bone marrow sample.	Whole blood (3 mL, EDTA) or bone marrow aspirate	Same day (sample received by 9 AM)	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion gene transcript level", "Minimal Residual Disease (MRD)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "10⁻⁴ – 10⁻⁵ (1 in 10,000–100,000 cells)"}, {"name": "Quantification", "reference_range": "Absolute transcript ratio (IS-calibrated)"}, {"name": "MRD Detection Limit", "reference_range": "0.001%"}] Preparation [] Indications ["Diagnosis of Chronic Myeloid Leukemia (CML)", "Diagnosis of Philadelphia-positive Acute Lymphoblastic Leukemia (Ph+ ALL)", "Monitoring molecular response to tyrosine kinase inhibitor (TKI) therapy", "Detection of Minimal Residual Disease (MRD)"] Measurement technique Confirm with laboratory Codes LOINC: 21644-6, 21645-3 ICD-10: C92.10, C91.00 Clinical summary This test quantifies the BCR-ABL1 fusion gene transcript level in a blood or bone marrow sample.
TEST-388 BCR-ABL Gene Rearrangement Qualitative PCR Test This test detects the presence or absence of the BCR-ABL1 fusion gene transcript, indicative of the Philadelphia chromosome translocation.	Whole Blood (EDTA) or Bone Marrow Aspirate	7–10 Business Days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion gene transcript", "Philadelphia chromosome translocation"] Parameters [] Preparation ["No fasting required", "Sample must be collected in an EDTA tube", "Sample must be transported refrigerated"] Indications ["Suspected Chronic Myeloid Leukemia (CML)", "Suspected Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)", "Initial diagnosis of leukemia"] Measurement technique Confirm with laboratory Codes LOINC: 55990-1 ICD-10: C92.10, C91.00, C92.00 Clinical summary This test detects the presence or absence of the BCR-ABL1 fusion gene transcript, indicative of the Philadelphia chromosome translocation.
TEST-1008 BCR-ABL Major Quantitative Test This test quantifies the BCR-ABL1 fusion transcript to monitor treatment response and detect minimal residual disease in CML patients.	Peripheral blood (preferred) or bone marrow aspirate (hospital collection only)	24–36 hours	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript level", "Minimal Residual Disease (MRD)"] Parameters [{"name": "Precision & Sensitivity", "reference_range": "International Scale (IS)‑calibrated, MR 4.0 , 99.9% precision"}] Preparation ["No fasting required", "Follow all pre-instructions, including signing the consent document and providing your complete clinical history", "Continue regular diet and medications unless otherwise directed by your physician"] Indications ["Monitoring treatment response in CML", "Detecting minimal residual disease (MRD) in CML"] Measurement technique Confirm with laboratory Codes LOINC: 51568-7 ICD-10: C92.1 Clinical summary This test quantifies the BCR-ABL1 fusion transcript to monitor treatment response and detect minimal residual disease in CML patients.
TEST-391 BCR-ABL Quantitative MRD Monitor Test This test evaluates the quantity of the BCR-ABL1 fusion transcript, a marker for Philadelphia chromosome-positive leukemias, to monitor minimal residual disease (MRD).	Peripheral whole blood (EDTA Lavender Top) or bone marrow aspirate	2–3 working days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcript", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 transcript level", "reference_range": "Reported on the International Scale (IS) as a percentage relative to a standardized baseline. MR3.0 (0.1% IS) or deeper is generally associated with improved outcomes."}] Preparation ["No fasting required", "Completed MRD Requisition Form (Form 22) with prior molecular results and current medication list is mandatory"] Indications ["Monitoring treatment response in CML", "Monitoring treatment response in Ph+ ALL", "Assessing molecular remission depth", "Detecting early molecular relapse", "Guiding therapy adjustments"] Measurement technique Confirm with laboratory Codes LOINC: 93923-2 ICD-10: C92.1, C91.0 Clinical summary This test evaluates the quantity of the BCR-ABL1 fusion transcript, a marker for Philadelphia chromosome-positive leukemias, to monitor minimal residual disease (MRD).
TEST-1826 BCR-ABL Variant Panel (Mbcr-b2a2, b3a2, b2a3) Test This test identifies specific BCR-ABL gene fusion transcripts (b2a2, b3a2, b2a3) in bone marrow or peripheral blood.	Bone Marrow / Peripheral Blood	5–7 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL fusion transcripts (b2a2, b3a2, b2a3)", "Presence of specific breakpoint cluster region variants"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant medications"] Indications ["Diagnosis of CML", "Diagnosis of Ph+ ALL", "Monitoring treatment response in CML/Ph+ ALL", "Risk stratification based on BCR-ABL variant"] Measurement technique Confirm with laboratory Codes LOINC: 33754-4 ICD-10: C92.1 Clinical summary This test identifies specific BCR-ABL gene fusion transcripts (b2a2, b3a2, b2a3) in bone marrow or peripheral blood.
TEST-1819 BCR-ABL1 Quantitative (p210, p190, p230) Test This test quantifies BCR-ABL1 fusion transcripts (p210, p190, p230) in peripheral blood to monitor treatment response in CML and Ph+ ALL.	Peripheral blood	3–4 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BCR-ABL1 fusion transcripts (p210, p190, p230)", "Minimal Residual Disease (MRD)"] Parameters [{"name": "BCR-ABL1 p210", "reference_range": "Reported as a percentage on the International Scale (IS)"}, {"name": "BCR-ABL1 p190", "reference_range": "Reported as a percentage on the International Scale (IS)"}, {"name": "BCR-ABL1 p230", "reference_range": "Reported as a percentage on the International Scale (IS)"}] Preparation ["No fasting is necessary.", "Inform the phlebotomist of all current medications and any recent fever."] Indications ["Monitoring treatment response in CML", "Monitoring treatment response in Ph+ ALL", "Assessing MRD"] Measurement technique Confirm with laboratory Codes LOINC: 34815-6 ICD-10: C92.1 Clinical summary This test quantifies BCR-ABL1 fusion transcripts (p210, p190, p230) in peripheral blood to monitor treatment response in CML and Ph+ ALL.

Category overview

BCR-ABL: overview

Confronting a blood cancer diagnosis like CML or ALL requires precise molecular insights, and unlocking your genetic blueprint provides a clear path forward for effective, targeted care. Within our Molecular Diagnostics portfolio, our BCR-ABL testing employs cutting-edge molecular sequencing to detect this specific chromosomal translocation associated with leukemia. Rather than acting as a final clinical diagnosis, this deeply specific BCR-ABL genetic data empowers your hematologist-oncologist with the foundational insights required to tailor preventive medical guidance and targeted therapies. Trusted among leading diagnostic labs in Dubai and the UAE, DNA Labs UAE guarantees uncompromising patient confidentiality alongside remarkably swift, accurate turnaround times. Prioritize your targeted oncology journey: discover our BCR-ABL testing in the UAE below to book an appointment, arrange a convenient home sample collection, or consult our specialized medical team.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.